Transcatheter heart valves technologies

Muscle fat index is associated with frailty and length of hospital stay following transcatheter aortic valve replacement in high-risk patients

Published on 27/01/2022 | Heidari et al. | International Journal of Cardiology 2022; 348(1 February 2022): 33-8 | 0 minute read

Transcatheter heart valves technologies

The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification

Published on 27/01/2022 | Hector R. CajigasMD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30057 | 16 minute read

Abstract Objectives To assess the impact of pulmonary hypertension (PH) on outcomes of patients with severe mitral annular calcification (MAC)

Transcatheter heart valves technologies

Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?

Published on 20/01/2022 | GiulioRusso @giuliorus 1 et al. | European Journal of Heart Failure 2021; AOP: 10.1002/ejhf.2398 | 41 minute read

Abstract Tricuspid regurgitation (TR) is a highly prevalent valvular heart disease and is associated with an increased risk of cardiovascular

Transcatheter heart valves technologies

Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta‐analysis

Published on 20/01/2022 | Thomas M.DasMD 1 et al. | Catheterization and Cardiovascular Interventions 2021; AOP: 10.1002/ccd.30009 | 16 minute read

Abstract Objectives We aimed to evaluate the risk of procedural complications after TAVR using secondary radial access (RA) versus femoral

Transcatheter heart valves technologies

Proposal criteria of paradoxical low-flow low-gradient aortic stenosis for predicting prognosis in patients undergoing transcatheter aortic valve implantation

Published on 20/12/2021 | Tomomi Tanino 1 et al. | Heart and Vessels 2021; aop: 10.1007/s00380-021-01992-y | 21 minute read

Abstract Background Paradoxical low-flow, low-gradient (PLF-LG) aortic stenosis (AS) is associated with poor prognosis in patients undergoing transcatheter aortic valve

Transcatheter heart valves technologies

Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis

Published on 20/12/2021 | Stephanie Louise Swift 1 et al. | BMJ Open 2021; 11(12): e054222 | 47 minute read

Abstract Objectives Patients undergoing surgery for severe aortic stenosis (SAS) can be treated with either transcatheter aortic valve implantation (TAVI)

Transcatheter heart valves technologies

Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review

Published on 10/11/2021 | Michele Gallo et al. | European journal of cardio-thoracic surgery 2021; aop: 10.1093/ejcts/ezab443 | 21 minute read

Abstract Objectives Transcatheter aortic valve replacement (TAVR) represents a valid treatment for patients with aortic valve stenosis and high or

Transcatheter heart valves technologies

Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement

Published on 10/11/2021 | AymanElbadawiMD 1 et al. | Catheterization and Cardiovascular Interventions 2021; AOP: 10.1002/ccd.29963 | 20 minute read

Abstract Background There is a paucity of real‐world data regarding the temporal trends and outcomes of trans‐septal transcatheter mitral valve

Transcatheter heart valves technologies

Direct transaortic transcather valve-in-valve implantation into a mechanical aortic valve prosthesis during left ventricular assist device implantation: description of a surgical technique

Published on 08/11/2021 | Philipp Kiefer et al. | Interactive CardioVascular and Thoracic Surgery 2021; aop: 10.1093/icvts/ivab253 | 6 minute read

Abstract The presence of a mechanical aortic valve prosthesis is considered a relative contraindication for left ventricular assist device implantation

Transcatheter heart valves technologies

Postprocedural Troponin Elevation and Mortality After Transcatheter Aortic Valve Implantation

Published on 08/11/2021 | Matthias Schindler PhD 1 et al. | Journal of the American Heart Association 2021; 10(21): 020739 | 22 minute read

Abstract Background This study sought to investigate the role of postprocedural troponin elevations in mortality prediction after transcatheter aortic valve

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.